Abstract:The natural ligands of two major human immunodeficiency virus type 1 (HIV-1) co-receptors, CXCR4 and CCR5, can profoundly inhibit the replication of HIV-1 that uses these co-receptors for entry into the target cells. It has been postulated that these natural chemokines inhibit HIV-1 infection by blocking common binding sites on CXCR4 or CCR5 that are required for HIV-1 envelope glycoprotein gp120 interaction with its co-receptor and/or by inducing receptor internalization. To investigate whether receptor internalization caused by stromal cell-derived factor (SDF)-1 alpha, a natural ligand of CXCR4, plays a role in its anti-HIV activity, we applied the SMM (synthetically and modularly modified)chemokine approach to generate a functional probe of SDF-1 alpha that retains significant CXCR4 binding but does not induce CXCR4 internalization. The antiviral study of this functional probe analog versus wild-type SDF-1 alpha showed that, despite the significant CXCR4 binding activity, this probe analog displayed a complete loss of effect in causing CXCR4 internalization and greatly diminished antiviral activity. Interestingly, this new analog also showed a decreased number of overlapping binding sites with HIV-1 on CXCR4 transmembrane and extracellular domains. The correlation of the decrease in the anti-HIV activity with the loss of CXCR4 internalization observed with this probe molecule suggests that receptor internalization may play an important role in the anti-HIV activity of SDF-1 alpha and possibly other natural chemokines. This further implies that any modifications in SDF-1a that result in a reduction or loss of internalization activity may result in analogs that are not suitable as effective HIV-1 inhibitors that target CXCR4, unless such modifications also result in improved CXCR4 interaction with increased number of overlapping binding sites with HIV-1, thus leading to more effective steric hindrance against HIV-1.

C-terminal Peptides of Chemokine-Like Factor 1 Signal Through Chemokine Receptor CCR4 to Cross-Desensitize the CXCR4.

Two C-terminal Peptides of Human CKLF1 Interact with the Chemokine Receptor CCR4.

Chemokine-like Factor 1 is a Functional Ligand for CC Chemokine Receptor 4 (CCR4)

Interactions of Peptides from Secreted Human CKLF1 and the N-Terminal Extracellular Tail of CCR4 Analyzed by CZE

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

The Cklf1-C19 Peptide Attenuates Allergic Lung Inflammation by Inhibiting Ccr3- and Ccr4-Mediated Chemotaxis in A Mouse Model of Asthma

Effects of Chemokine-Like Factor 1 on Vascular Smooth Muscle Cell Migration and Proliferation in Vascular Inflammation.

Expression of Chemokine-Like Factor 1 is Upregulated During T Lymphocyte Activation

Molecular Cloning and Characterization of Chemokine-Like Factor 1 (CKLF1), a Novel Human Cytokine with Unique Structure and Potential Chemotactic Activity.

The chemokine-like factor 1 induces asthmatic pathological change by activating nuclear factor-κB signaling pathway

Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues.

Structural Basis of the Interactions Between Cxcr4 and Cxcl12/Sdf-1 Revealed by Theoretical Approaches

Role Of Cxcr4 Internalization In The Anti-Hiv Activity Of Stromal Cell-Derived Factor-1 Alpha Probed By A Novel Synthetically And Modularly Modified-Chemokine Analog

Structural insights into the activation and inhibition of CXC chemokine receptor 3

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

CXCL4 signaling and gene induction in human monocytes

CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis

CXCR3-binding chemokines: novel multifunctional therapeutic targets

Expressional and Functional Studies of CKLF1 During Dendritic Cell Maturation.

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans